JP2006524243A5 - - Google Patents

Download PDF

Info

Publication number
JP2006524243A5
JP2006524243A5 JP2006509825A JP2006509825A JP2006524243A5 JP 2006524243 A5 JP2006524243 A5 JP 2006524243A5 JP 2006509825 A JP2006509825 A JP 2006509825A JP 2006509825 A JP2006509825 A JP 2006509825A JP 2006524243 A5 JP2006524243 A5 JP 2006524243A5
Authority
JP
Japan
Prior art keywords
use according
animal
syndrome
cognitive
training
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006509825A
Other languages
English (en)
Japanese (ja)
Other versions
JP4833834B2 (ja
JP2006524243A (ja
Filing date
Publication date
Priority claimed from US10/410,508 external-priority patent/US20040224316A1/en
Application filed filed Critical
Publication of JP2006524243A publication Critical patent/JP2006524243A/ja
Publication of JP2006524243A5 publication Critical patent/JP2006524243A5/ja
Application granted granted Critical
Publication of JP4833834B2 publication Critical patent/JP4833834B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006509825A 2003-04-08 2004-04-08 増強認知訓練 Expired - Fee Related JP4833834B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/410,508 2003-04-08
US10/410,508 US20040224316A1 (en) 2000-08-10 2003-04-08 Augmented cognitive training
PCT/US2004/010876 WO2004091609A2 (en) 2001-08-10 2004-04-08 Phosphodiesesterase 4 inhibitors for the treatment of a cognitive deficit

Publications (3)

Publication Number Publication Date
JP2006524243A JP2006524243A (ja) 2006-10-26
JP2006524243A5 true JP2006524243A5 (https=) 2011-03-24
JP4833834B2 JP4833834B2 (ja) 2011-12-07

Family

ID=37416211

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006509825A Expired - Fee Related JP4833834B2 (ja) 2003-04-08 2004-04-08 増強認知訓練

Country Status (7)

Country Link
US (2) US20040224316A1 (https=)
EP (4) EP2116240B1 (https=)
JP (1) JP4833834B2 (https=)
AT (1) ATE556707T1 (https=)
CA (1) CA2521839C (https=)
ES (3) ES2509093T3 (https=)
WO (1) WO2004091609A2 (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7868015B2 (en) 2000-08-10 2011-01-11 Cold Spring Harbor Laboratory Phosphodiesesterase 4 inhibitors for the treatment of a cognitive deficit
EP2316531A1 (en) * 2000-08-10 2011-05-04 Cold Spring Harbor Laboratory Augmented cognitive training
US8153646B2 (en) 2000-08-10 2012-04-10 Dart Neuroscience (Cayman) Ltd. Phosphodiesterase 4 inhibitors for cognitive and motor rehabilitation
US9931318B2 (en) 2003-04-08 2018-04-03 Dart Neuroscience (Cayman) Ltd. Phosphodiesterase 4 inhibitors for cognitive and motor rehabilitation
US8975216B2 (en) * 2006-03-30 2015-03-10 Pacific Biosciences Of California Articles having localized molecules disposed thereon and methods of producing same
ES2412481T3 (es) * 2006-05-19 2013-07-11 Dart Neuroscience Llc Inhibidores de la fosfodiesterasa 4 para la rehabilitación motora
GB0722769D0 (en) * 2007-11-21 2008-01-02 Biolipox Ab New compounds
EP2137150A1 (en) * 2007-03-12 2009-12-30 Biolipox AB Piperidinones useful in the treatment of inflammation
CA2684920A1 (en) * 2007-05-15 2008-11-27 Helicon Therapeutics, Inc. Methods of treating cognitive disorders by inhibition of gpr12
BRPI0811623A2 (pt) * 2007-05-15 2014-11-11 Helicon Therapeutics Inc Métodos para identificar genes envolvidos na formação de memória usando pequeno rna interferente (sirna)
JP5049713B2 (ja) * 2007-09-14 2012-10-17 株式会社コナミデジタルエンタテインメント ゲームシステム並びにこれを構成するゲーム装置及び課題報知装置
KR20110049801A (ko) * 2008-07-18 2011-05-12 다트 뉴로사이언시즈, 엘엘씨 기억 물질의 평가를 위한 방법 및 시스템
WO2011114103A1 (en) 2010-03-18 2011-09-22 Biolipox Ab Pyrimidinones for use as medicaments
US20150050626A1 (en) * 2013-03-15 2015-02-19 Dart Neuroscience, Llc Systems, Methods, and Software for Improving Cognitive and Motor Abilities
WO2015144598A1 (en) * 2014-03-28 2015-10-01 Algiax Pharmaceuticals Gmbh Treatment of cognitive disorders
JP2017141222A (ja) * 2016-02-09 2017-08-17 国立大学法人帯広畜産大学 パーキンソン病に併発した認知障害の治療剤及びそのスクリーニング方法
WO2022156727A1 (zh) 2021-01-21 2022-07-28 浙江养生堂天然药物研究所有限公司 治疗肿瘤的组合物及方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5479508A (en) * 1991-05-22 1995-12-26 Zenith Electronics Corp. Method of operating a pay per view television system
US5547979A (en) * 1992-03-30 1996-08-20 Smithkline Beecham TNF inhibition
US5552438A (en) 1992-04-02 1996-09-03 Smithkline Beecham Corporation Compounds useful for treating allergic and inflammatory diseases
EP0651824A4 (en) 1992-04-10 1997-02-26 Fox Chase Cancer Center TRANSCRIPTION ELEMENT FOR CONTROLLING THE INCREASED GENE EXPRESSION IN MYOBLASTEN.
WO1996006843A1 (en) * 1994-08-29 1996-03-07 Yamanouchi Pharmaceutical Co., Ltd. Novel naphthyridine derivative and medicinal composition thereof
US5619249A (en) * 1994-09-14 1997-04-08 Time Warner Entertainment Company, L.P. Telecasting service for providing video programs on demand with an interactive interface for facilitating viewer selection of video programs
US6689557B1 (en) 1994-10-07 2004-02-10 Cold Spring Harbor Laboratory Method of identifying a substance that affects long term memory and CREM/CREB/ATF-1 subfamily members
US5929223A (en) * 1994-10-07 1999-07-27 Cold Spring Harbor Laboratory Cloning and characterizing of genes associated with long-term memory
US5652749A (en) * 1995-02-03 1997-07-29 International Business Machines Corporation Apparatus and method for segmentation and time synchronization of the transmission of a multiple program multimedia data stream
US5793410A (en) * 1995-05-26 1998-08-11 Hyundai Electronics America Video pedestal network
US5801030A (en) 1995-09-01 1998-09-01 Genvec, Inc. Methods and vectors for site-specific recombination
ATE256476T1 (de) * 1996-11-15 2004-01-15 Kennedy Inst Of Rheumatology Unterdrückung von tnfalpha und il-12 in der therapie
BR9806752A (pt) * 1997-01-15 2000-03-14 Byk Gulden Lomberg Chem Fab Ftalazinonas.
DE69919179T2 (de) 1998-09-09 2005-07-28 Inflazyme Pharmaceuticals, Ltd., Richmond Substituierte gamma-phenyl-delta-lactone und deren analoge, und ihre verwendungen
IT1303272B1 (it) 1998-10-29 2000-11-06 Zambon Spa Derivati triciclici inibitori della fosfodiesterasi 4
EP1157007A1 (en) 1999-02-25 2001-11-28 Merck Frosst Canada Inc. Pde iv inhibiting compounds, compositions and methods of treatment
US6436965B1 (en) 2000-03-02 2002-08-20 Merck Frosst Canada & Co. PDE IV inhibiting amides, compositions and methods of treatment
CA2402384A1 (en) 2000-03-16 2001-09-20 Inflazyme Pharmaceuticals Ltd. Benzylated pde4 inhibitors
EP2316531A1 (en) * 2000-08-10 2011-05-04 Cold Spring Harbor Laboratory Augmented cognitive training
ATE463739T1 (de) * 2002-08-19 2010-04-15 Helicon Therapeutics Inc Screening-verfahren für kognitive erweiterungsvorrichtungen

Similar Documents

Publication Publication Date Title
JP2006524243A5 (https=)
Beaudin et al. Impact of obstructive sleep apnoea and intermittent hypoxia on cardiovascular and cerebrovascular regulation
Kemeny et al. Emotions, the neuroendocrine and immune systems, and health
JP2019031502A5 (https=)
WO2004026246A3 (en) Methods of treating age associated memory impairment (aami), mild cognitive impairment (mci), and dementias with cell cycle inhibitors
JP2018520189A5 (https=)
EA200700427A1 (ru) Предупреждение и лечение синуклеинопатических и амилоидогенных заболеваний
WO2017178807A1 (en) Use of cannabidivarin in the treatment of autism spectrum disorder, associated disorders and schizophrenia
WO2004030524A3 (en) Treatment of autism and similar disorders
Guercio et al. Improving cognitive training for schizophrenia using neuroplasticity enhancers: Lessons from decades of basic and clinical research
ATE424824T1 (de) Verfahren zur verhütung oder behandlung von herzarrhythmie
DE602005025347D1 (de) Oligoribonukleotide und verfahren zu deren anwendung bei der behandlung von fibrotischen leiden und anderen krankheiten
JP2009537568A5 (https=)
JP5517925B2 (ja) パーキンソン病治療薬
JP5517926B2 (ja) パーキンソン病治療薬
Badran et al. Recovery Mimicking “Ideal” CPAP Adherence Does Not Improve Wakefulness or Cognition in Chronic Murine Models of OSA: Effect of Wake-Promoting Agents
Tellez et al. Autoradiographic study of serotonin transporter during memory formation
Ferreira et al. Health care reform or more affordable health care?
Li et al. Nicotinic acetylcholine signaling is required for motor learning but not for rehabilitation from spinal cord injury
JP2025509709A (ja) 発症前神経変性状態の調査診断としてのセルフリーｄｎａからの神経メチル化シグネチャー
RU2005114505A (ru) Применение (2-имидазолин-2-иламино) хиноксалинов для лечения деменции и болезни паркинсона
Mattson Exercise and the brain: a slap on the HAND
ATE432070T1 (de) Herabgesetzte dosis von tolterodin zur behandlung von harnwegserkrankungen
Doe et al. Behavioral despair during a water maze learning task in mice
JP2012090626A (ja) 疲労の評価方法